Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Melanoma Research|June 17, 2014
Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanomaSamantha E Bowyer, Aparna D Rao, Megan Lyle, et al.
Cancers|December 11, 2025
Low pH, High Stakes: A Narrative Review Exploring the Acid-Sensing GPR65 Pathway as a Novel Approach in Renal Cell CarcinomaMichael Grant, Barbara Cipriani, Alastair Corbin, et al.
Cancers|March 14, 2026
Correction: Grant et al. Low pH, High Stakes: A Narrative Review Exploring the Acid-Sensing GPR65 Pathway as a Novel Approach in Renal Cell Carcinoma. Cancers 2025, 17, 3883Michael Grant, Barbara Cipriani, Alastair Corbin, et al.
Clinical Genitourinary Cancer|July 30, 2013
A phase II safety and efficacy study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor pazopanib in patients with metastatic urothelial cancerRoberto Pili, Rui Qin, P J Flynn, et al.
Translational Lung Cancer Research|April 11, 2022
Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancerEmmanuel Acheampong, Afaf Abed, Michael Morici, et al.
Cancer|January 14, 2009
A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanomaAhmad A Tarhini, Michael Millward, Paul Mainwaring, et al.
The Lancet. Oncology|August 6, 2019
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trialMichael Friedlander, Tarek Meniawy, Ben Markman, et al.
Asia-Pacific Journal of Clinical Oncology|December 2, 2016
Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologistsVictoria Atkinson, Georgina V Long, Alexander M Menzies, et al.
Cancers|February 17, 2019
Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome ProfilesCarlos Aya-Bonilla, Elin S Gray, Jayapal Manikandan, et al.
British Journal of Cancer|March 14, 2018
A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumoursKeith Dredge, Todd V Brennan, Edward Hammond, et al.
Pageof 15